Skip to main content

Table 1 Feasibility outcomes

From: A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study

Trial feasibility measure—proportion of… Percentage (n/total N) 95% confidence interval
Patients screened as eligible (Bristol) 39.2% (71/181) [32.1, 46.7]
Patients screened as eligible (London) 13.1% (78/595) [10.5, 16.1]
Eligible patients consented 34.9% (52/149) [27.2, 43.1]
Consented participants randomised 65.4% (34/52) [50.9, 78.0]
Randomised participants with baseline questionnaire data 91.2% (31/34) [76.3, 98.1]
Randomised participants with 3-month questionnaires 67.6% (23/34) [49.5, 82.6]
Surviving randomised participants with 6-month questionnaires 55.9% (19/34) [37.9, 72.8]
Group 1 participants with 15-month questionnaires 55.5% (5/9) [21.2, 86.3]
Participants with baseline, 3- and 6-month questionnaire data 55.9% (19/34) [37.9, 72.8]